About Acetylon
Acetylon is a company based in Boston (United States) founded in 2008 by Marc Cohen was acquired by Celgene in December 2016.. Acetylon has raised $138.24 million across 6 funding rounds from investors including HHS, Celgene and The Kraft Group. The company has 37 employees as of December 31, 2015. Acetylon operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Boston, United States
- Employees 37 as on 31 Dec, 2015
- Founders Marc Cohen
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Acetylon Pharmaceuticals Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Acetylon
Acetylon has successfully raised a total of $138.24M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $367.97 thousand completed in August 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $367,972
-
First Round
First Round
(07 Aug 2009)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2013 | Amount | Grant - Acetylon | Valuation |
investors |
|
| Jul, 2013 | Amount | Series B - Acetylon | Valuation | Celgene |
|
| Feb, 2012 | Amount | Series B - Acetylon | Valuation | Celgene |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Acetylon
Acetylon has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Celgene and The Kraft Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments and family assets are managed by The Kraft Group.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Therapies for cancer and inflammatory diseases are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Acetylon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Acetylon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Acetylon Comparisons
Competitors of Acetylon
Acetylon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Acetylon
When was Acetylon founded?
Acetylon was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is Acetylon located?
Acetylon is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Acetylon?
Mark Alles is the current CEO of Acetylon.
Is Acetylon a funded company?
Acetylon is a funded company, having raised a total of $138.24M across 6 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Aug 07, 2009.
How many employees does Acetylon have?
As of Dec 31, 2015, the latest employee count at Acetylon is 37.
What does Acetylon do?
Acetylon Pharmaceuticals, Inc. intends to manufacture small molecule drugs to realize the therapeutic potential of histone deacetylase. The company is pursuing development of next-generation, selective histone deacetylase (HDAC) enzyme inhibitors with potential for treatment of hematologic and solid tumor cancers, inflammatory diseases such as rheumatoid arthritis, neurodegenerative diseases such as Parkinsons, genetic diseases incluidng sickle cell disease and thalassemia major, and infectious disease such as malaria. Acetylons technology is being licensed from Harvard University and the Dana Farber Cancer Center. Acetylons lead drug candidate, ricolinostat (ACY-1215), is currently in clinical trials for the treatment of multiple myeloma and lymphoma.
Who are the top competitors of Acetylon?
Acetylon's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Acetylon's investors?
Acetylon has 3 investors. Key investors include HHS, Celgene, and The Kraft Group.